https://www.epo.org/en/boards-of-appeal/decisions/t182453eu1
T 2453/18 (Risperidone / INDIVIOR) of 22.11.2021
risperidoneindivior
https://opiant.com/en/media/press-releases/claim-filed-by-reckitt-benckiser-group-plc
Indivior | Claim filed by Reckitt Benckiser Group plc
reckitt benckiserindiviorclaimfiledgroup
https://www.epo.org/de/boards-of-appeal/decisions/t182783eu1
T 2783/18 (Risperidone sustained delivery/INDIVIOR) vom 19.07.2021
risperidonesustained
https://www.clinicaltrialsarena.com/news/newsindivior-reports-positive-topline-phase-iii-trial-results-of-rbp-6000-to-treat-opioid-use-disorder-4981013/
Indivior reports positive topline Phase III trial results of RBP-6000 to treat opioid use disorder...
Aug 17, 2016 - US-based pharmaceutical company Indivior has reported positive topline results from its pivotal Phase III clinical trial of RBP-6000 for opioid use disorder.
https://opiant.com/en/media/press-releases/%20indivior-appoints-tony-kingsley-to-the-board-of-directors
Indivior | Indivior Appoints Tony Kingsley to the Board of Directors
to theboard ofindiviortonykingsley
https://opiant.com/en/media/press-releases/indivior-to-participate-in-upcoming-investor-events%20
Indivior | Indivior to Participate in Upcoming Investor Events
to participateindiviorupcominginvestorevents
https://opiant.com/en/media/press-releases/indivior_to_commence_trading_on_Nasdaq
Indivior | Indivior to Commence Trading on Nasdaq
indiviorcommencetradingnasdaq
https://opiant.com/en/media/press-releases/shaun-thaxter-ceo-of-indivior-plc-presented-at-the-jp-morgan-health-care-conference
Indivior | Shaun Thaxter, CEO of Indivior PLC presented at the JP Morgan Healthcare Conference in...
https://www.opiant.com/en/media/press-releases/indivior-rbp-7000-top-line-results
Indivior | Indivior RBP-7000 Top-line results
top lineindiviorrbpresults
https://www.addextherapeutics.com/en/investors/press-releases/addex-and-indivior-extend-research-collaboration-gabab-positive-allosteric-modulators-indivior-commits-4-million-new-funding/
Addex therapeutics :: Addex and Indivior Extend Research Collaboration on GABAB Positive Allosteric...
research collaborationaddextherapeuticsindiviorextend
https://opiant.com/en/media/press-releases/Indivior-CPDD-2022
Indivior | Indivior Announces Seven Abstracts Accepted for Presentation at the 84th Annual...
Richmond, VA, June 8, 2022
at theindiviorannouncessevenabstracts
https://opiant.com/en/media/press-releases/indivior-submits-new-drug-application-to-us-fda-for-rbp-7000-risperidone-monthly-depot
Indivior | Indivior Submits New Drug Application to U.S. FDA for RBP-7000 Risperidone Monthly Depot...
https://www.indivior.com/latest/category/financial-news/2020/annual-report-and-accounts-2019-and-agm-2020
Indivior | Annual Report & Accounts 2019 and Annual General Meeting 2020 | Indivior
annual report accountsgeneral meetingindivior
https://opiant.com/en/media/press-releases/Indivior-Q3-2021-Results
Indivior | Indivior Announces Q3 and Nine Months 2021 Results; Raises FY 2021 Guidance
Richmond, VA, and Slough, UK, October 28, 2021
nine monthsindiviorannounces
https://www.marketinout.com/stock/indv
Indivior Pharmaceuticals Inc (INDV) Quotes and Fundamentals
Indivior Pharmaceuticals Inc (INDV) Quotes, Fundamentals, Technicals, Relative Strength, Financial Ratios, and Dividends
indiviorpharmaceuticalsincquotesfundamentals
https://opiant.com/en/media/press-releases/indivior-announces-q1-2023-financial-results
Indivior | Indivior Announces Q1 2023 Financial Results
indiviorannouncesfinancialresults
https://www.indivior.com/latest/category/financial-news/2022/indv-q3-2022-announcement
Indivior | Indivior to Announce Q3 / 9 Months YTD 2022 Results and Host Webcast on October 27th |...
https://ch.marketscreener.com/kurs/aktie/INDIVIOR-PHARMACEUTICALS--19344116/derivatives-optionsscheine/
Indivior Pharmaceuticals, Inc.: Optionsscheine CALL PUT | A42086 | US45579U1097 | MarketScreener...
Indivior Pharmaceuticals, Inc.: Optionsscheine Call und Put Aktie Indivior Pharmaceuticals, Inc. | A42086 | London S.E.
indiviorpharmaceuticalsincoptionsscheinecall
https://opiant.com/en/media/press-releases/indivior-announces-first-half-and-second-quarter-2020-results
Indivior | Indivior Announces First Half and Second Quarter 2020 Results
first halfsecond quarterindiviorannouncesresults
https://opiant.com/en/media/press-releases/Court%20Provides%20Final%20Approval%20of%20Settlement%20with%20Direct%20Purchaser%20Class%20in%20the%20Multidistrict%20Antitrust%20Litigation%3B%20Final-Court-Approval-Concludes-the-Antitrust-Multidistrict-Litigation
Indivior | Court Provides Final Approval of Settlement with Direct Purchaser Class in the...
https://www.pharmaceuticalprocessingworld.com/tag/indivior-solutions/
Indivior Solutions Archives - Pharmaceutical Processing World
pharmaceutical processingindiviorsolutionsarchivesworld